ITV News Health Correspondent Rebecca Barry and Senior Producer Liz Little investigate the “lethal” skinny jab black market. | ITV National News ...

Adult patients taking Wegovy saw a reduced risk of experiencing a major adverse cardiovascular event within the first three months of treatment, according to a secondary analysis of the drug’s ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...

Pharma major Biocon says its businesses are at a promising inflection point, with strong momentum expected to continue.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs get a prescription for it, a new ...

A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...